{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T20:03:54Z","timestamp":1764187434848,"version":"3.46.0"},"reference-count":239,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gastroenterol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1055\/a-2189-8461","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T20:12:15Z","timestamp":1704831135000},"page":"73-109","source":"Crossref","is-referenced-by-count":0,"title":["S3-Leitlinie \u201eDiagnostik und Therapie des Hepatozellul\u00e4ren Karzinoms\u201c \u2013 Kurzversion"],"prefix":"10.1055","volume":"62","author":[{"given":"Sabrina","family":"Gro\u00df","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Gastroenterologie, Gastrointestinale Onkologie, Hepatologie, Infektiologie und Geriatrie, Eberhard-Karls Universit\u00e4t, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bitzer","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Gastroenterologie, Gastrointestinale Onkologie, Hepatologie, Infektiologie und Geriatrie, Eberhard-Karls Universit\u00e4t, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Albert","sequence":"additional","affiliation":[{"name":"Katharinenhospital, Klinik f\u00fcr Allgemeine Innere Medizin, Gastroenterologie, Hepatologie, Infektiologie und Pneumologie, Stuttgart"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Bl\u00f6dt","sequence":"additional","affiliation":[{"name":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.\u200aV.(AWMF), Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Boda-Heggemann","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Strahlentherapie und Radioonkologie, Universit\u00e4tsklinikum Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Brunner","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik f\u00fcr Strahlentherapie-Radioonkologie, Medizinische Universit\u00e4t Graz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Caspari","sequence":"additional","affiliation":[{"name":"Klinik Niederrhein Erkrankungen des Stoffwechsels der Verdauungsorgane und Tumorerkrankungen, Bad\u00a0Neuenahr-Ahrweiler"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"De Toni","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik II, LMU M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Dombrowski","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie, Universit\u00e4t Greifswald"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Evert","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie, Universit\u00e4t Regensburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Follmann","sequence":"additional","affiliation":[{"name":"Office des Leitlinienprogrammes Onkologie, Deutsche Krebsgesellschaft e.\u200aV., Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Freudenberger","sequence":"additional","affiliation":[{"name":"Clinical Guideline Services GmbH (CGS), Berlin\/Kiel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cihan","family":"Gani","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Radioonkologie, Universit\u00e4tsklinikum T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Geier","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik II, Universit\u00e4tsklinikum W\u00fcrzburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Gkika","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Strahlenheilkunde, Department f\u00fcr Radiologische Diagnostik und Therapie, Universit\u00e4tsklinikum Freiburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"G\u00f6tz","sequence":"additional","affiliation":[{"name":"Medizinische Klinik IV \u2013 Gastroenterologie\/Onkologie, Klinikverbund S\u00fcdwest, B\u00f6blingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Helmberger","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Radiologie, Neuroradiologie und minimal invasive Therapie, M\u00fcnchen Klinik Bogenhausen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf-Thorsten","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Institut und Poliklinik f\u00fcr Diagnostische und Interventionelle Radiologie, Universit\u00e4tsklinikum Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Huppert","sequence":"additional","affiliation":[{"name":"Radiologisches Zentrum, Max Grundig Klinik, B\u00fchlerh\u00f6he"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Krug","sequence":"additional","affiliation":[{"name":"Strahlentherapie Campus Kiel, Universit\u00e4tsklinikum Schleswig-Holstein"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian La","family":"Foug\u00e8re","sequence":"additional","affiliation":[{"name":"Nuklearmedizin und Klinische Molekulare Bildgebung, Eberhard-Karls Universit\u00e4t, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hauke","family":"Lang","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Allgemein-, Viszeral- und Transplantationschirurgie, Johannes Gutenberg-Universit\u00e4t, Mainz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Langer","sequence":"additional","affiliation":[{"name":"Office des Leitlinienprogrammes Onkologie, Deutsche Krebsgesellschaft e.\u200aV., Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Lenz","sequence":"additional","affiliation":[{"name":"Zentrale Einrichtung Palliativmedizin, Universit\u00e4tsklinikum M\u00fcnster"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"L\u00fcdde","sequence":"additional","affiliation":[{"name":"Medizinische Klinik f\u00fcr Gastroenterologie, Hepatologie und Infektiologie, Universit\u00e4tsklinikum D\u00fcsseldorf"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Mahnken","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Diagnostische und Interventionelle Radiologie, Universit\u00e4tsklinikum Marburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Nadalin","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Allgemein-, Viszeral- und Transplantationschirurgie, Eberhard-Karls Universit\u00e4t, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoa Huu Phuc","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Humangenetik, Ruhr-Universit\u00e4t, Bochum"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Nothacker","sequence":"additional","affiliation":[{"name":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.\u200aV.(AWMF), Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Ockenga","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II, Gesundheit Nord, Klinikverbund Bremen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Oldhafer","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Leber-, Gallenwegs- und Pankreaschirurgie, Asklepios Klinik Barmbek"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Paprottka","sequence":"additional","affiliation":[{"name":"Sektion f\u00fcr Interventionelle Radiologie, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Pereira","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Radiologie, Minimal-invasive Therapien und Nuklearmedizin, SLK-Klinken Heilbronn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Persigehl","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Diagnostische und Interventionelle Radiologie, Universit\u00e4tsklinikum K\u00f6ln"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Plentz","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin, Gesundheit Nord, Klinikverbund Bremen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Pohl","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Gastroenterologie, Asklepios Klinik Altona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Recken","sequence":"additional","affiliation":[{"name":"Hamburger Fern-Hochschule"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Reimer","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Diagnostische und Interventionelle Radiologie, St\u00e4dtisches Klinikum Karlsruhe"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Riemer","sequence":"additional","affiliation":[{"name":"Lebertransplantierte e.\u200aV."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Ritterbusch","sequence":"additional","affiliation":[{"name":"Hospizarbeit am Universit\u00e4tsklinikum Essen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Roeb","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II Pneumologie, Nephrologie und Gastroenterologie, Universit\u00e4tsklinikum Gie\u00dfen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rn","family":"R\u00fcssel","sequence":"additional","affiliation":[{"name":"Medizinische Klinik IV H\u00e4matologie und Onkologie, Universit\u00e4tsklinikum Halle (Saale)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Schellhaas","sequence":"additional","affiliation":[{"name":"Medizinische Klinik I Gastroenterologie, Pneumologie und Endokrinologie, Friedrich-Alexander-Universit\u00e4t, Erlangen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schirmacher","sequence":"additional","affiliation":[{"name":"Allgemeine Pathologie und pathologische Anatomie, Universit\u00e4tsklinikum Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J\u00fcrgen","family":"Schlitt","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Chirurgie, Universit\u00e4tsklinikum Regensburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Schmid","sequence":"additional","affiliation":[{"name":"Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital, LMU M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Schuler","sequence":"additional","affiliation":[{"name":"Medizinische Klinik, Gastroenterologie, Alb-Fils-Kliniken, Geislingen an der Steige"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Seehofer","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Viszeral-, Transplantations-, Thorax- und Gef\u00e4\u00dfchirurgie, Universit\u00e4tsklinikum Leipzig"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Sinn","sequence":"additional","affiliation":[{"name":"II. Medizinische Klinik und Poliklinik (Onkologie, H\u00e4matologie, Knochenmarktransplantation mit Abteilung f\u00fcr Pneumologie), Universit\u00e4tsklinikum Hamburg-Eppendorf"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Stengel","sequence":"additional","affiliation":[{"name":"Innere Medizin VI \u2013 Psychosomatische Medizin und Psychotherapie, Eberhard-Karls Universit\u00e4t, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Steubesand","sequence":"additional","affiliation":[{"name":"Clinical Guideline Services GmbH (CGS), Berlin\/Kiel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Stoll","sequence":"additional","affiliation":[{"name":"Klinik Herzogh\u00f6he Bayreuth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Tannapfel","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie, Ruhr-Universit\u00e4t Bochum"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Taubert","sequence":"additional","affiliation":[{"name":"Klinische Sozialarbeit, Universit\u00e4tsklinikum Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reina","family":"Tholen","sequence":"additional","affiliation":[{"name":"Deutscher Bundesverband f\u00fcr Physiotherapie (ZVK) e.\u200aV."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Trojan","sequence":"additional","affiliation":[{"name":"Medizinische Klinik 1: Gastroenterologie und Hepatologie, Pneumologie und Allergologie, Endokrinologie und Diabetologie sowie Ern\u00e4hrungsmedizin, Goethe-Universit\u00e4t, Frankfurt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"van Thiel","sequence":"additional","affiliation":[{"name":"Deutsche Leberhilfe e.\u200aV."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arndt","family":"Vogel","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Vogl","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Diagnostische und Interventionelle Radiologie, Goethe-Universit\u00e4t, Frankfurt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Wacker","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Diagnostische und Interventionelle Radiologie, Medizinische Hochschule Hannover"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Waidmann","sequence":"additional","affiliation":[{"name":"Onkologie Bethanien, Frankfurt am Main"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Wege","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Allgemeine Innere Medizin, Onkologie\/H\u00e4matologie, Gastroenterologie und Infektiologie, Klinikum Esslingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dane","family":"Wildner","sequence":"additional","affiliation":[{"name":"Innere Medizin, Krankenh\u00e4user N\u00fcrnberger Land GmbH, Standort Lauf"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus-Alexander","family":"W\u00f6rns","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Gastroenterologie, H\u00e4matologie und internistische Onkologie und Endokrinologie, Klinikum Dortmund"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Galle","sequence":"additional","affiliation":[{"name":"1. Medizinische Klinik und Poliklinik, Gastroenterologie, Hepatologie, Nephrologie, Rheumatologie, Infektiologie, Johannes Gutenberg-Universit\u00e4t, Mainz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisar","family":"Malek","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Gastroenterologie, Gastrointestinale Onkologie, Hepatologie, Infektiologie und Geriatrie, Eberhard-Karls Universit\u00e4t, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"J Bruix","year":"2011","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jvh.12727?download=true","article-title":"Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE-B score","volume":"24","author":"W P Brouwer","year":"2017","journal-title":"J Viral Hepat"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"G Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.30823?download=true","article-title":"Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents","volume":"71","author":"F Kanwal","year":"2020","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/liv.13142?download=true","article-title":"Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis","volume":"36","author":"E Raffetti","year":"2016","journal-title":"Liver Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"G V Papatheodoridis","year":"2015","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease","volume":"155","author":"F Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2147\/CLEP.S144368","article-title":"Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes","volume":"9","author":"J C Simeone","year":"2017","journal-title":"Clin Epidemiol"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/liv.15195","article-title":"Risk of hepatic and extrahepatic cancer in NAFLD: A population-based cohort study","volume":"42","author":"K Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Liver Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/dji040","article-title":"Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan","volume":"97","author":"M Inoue","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/CEJ.0000000000000252","article-title":"Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies","volume":"26","author":"F Bravi","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3945\/ajcn.115.116095","article-title":"The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition","volume":"102","author":"K Aleksandrova","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.gastro.2014.10.005","article-title":"Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort","volume":"148","author":"V W Setiawan","year":"2015","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","article-title":"Randomized controlled trial of screening for hepatocellular carcinoma","volume":"130","author":"B H Zhang","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/apt.12370","article-title":"Surveillance for hepatocellular cancer with ultrasonography vs computed tomography -- a randomised study","volume":"38","author":"C Pocha","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/hep.24545","article-title":"Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3-\u00a0and 6-month periodicities","volume":"54","author":"J C Trinchet","year":"2011","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis","volume":"154","author":"K Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2019.07.033","article-title":"Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores","volume":"157","author":"G N Ioannou","year":"2019","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/MEG.0000000000001226","article-title":"Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy","volume":"30","author":"B G Song","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/hep.1840380430","article-title":"MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation","volume":"38","author":"M Burrel","year":"2003","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/jmri.22588","article-title":"Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging","volume":"34","author":"H Haradome","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00330-012-2691-z","article-title":"Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging","volume":"23","author":"M Di Martino","year":"2013","journal-title":"Eur Radiol"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1055\/a-1220-8561","article-title":"Contrast-Enhanced Ultrasound Algorithms (CEUS-LIRADS\/ESCULAP) for the Noninvasive Diagnosis of Hepatocellular Carcinoma \u2013 A Prospective Multicenter DEGUM Study","volume":"42","author":"B Schellhaas","year":"2021","journal-title":"Ultraschall Med"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1007\/s00330-021-07872-3","article-title":"Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS\u00ae\/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study","volume":"31","author":"D Strobel","year":"2021","journal-title":"Eur Radiol"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.ultrasmedbio.2021.07.010","article-title":"Contrast-Enhanced Ultrasound Patterns for the Non-invasive Diagnosis of Hepatocellular Carcinoma: A Prospective Multicenter Study in Histologically Proven Liver Lesions in a Real-Life Setting Demonstrating the Benefit of Extended Late Phase Observation","volume":"47","author":"B Schellhaas","year":"2021","journal-title":"Ultrasound Med Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2010.07.025","article-title":"Optimization of imaging diagnosis of 1\u20132\u00a0cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization","volume":"54","author":"K Khalili","year":"2011","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1477-2574.2012.00617.x","article-title":"Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system","volume":"15","author":"A C Chan","year":"2013","journal-title":"HPB (Oxford)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-8278(99)80173-1","article-title":"A new prognostic classification for predicting survival in patients with hepatocellular carcinoma Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire","volume":"31","author":"S Chevret","year":"1999","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"P J Johnson","year":"2015","journal-title":"J Clin Oncol"},{"issue":"S 01","key":"ref30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000173428","article-title":"Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan Integrated Staging Score, the conventional Japan Integrated Staging Score and the BALAD Score","volume":"75","author":"S Kitai","year":"2008","journal-title":"Oncology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/cncr.10384","article-title":"Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients","volume":"94","author":"T W Leung","year":"2002","journal-title":"Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.20636","article-title":"Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort","volume":"41","author":"J A Marrero","year":"2005","journal-title":"Hepatology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jhep.2016.09.008","article-title":"The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma","volume":"66","author":"D J Pinato","year":"2017","journal-title":"J Hepatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.transproceed.2009.03.054","article-title":"Validation of the BCLC prognostic system in surgical hepatocellular cancer patients","volume":"41","author":"A Vitale","year":"2009","journal-title":"Transplant Proc"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma","volume":"146","author":"T Yau","year":"2014","journal-title":"Gastroenterology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104?articleTools=true","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"V Mazzaferro","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"V Mazzaferro","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"F Y Yao","year":"2001","journal-title":"Hepatology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/00365521.2016.1236396","article-title":"Impact of preoperative locoregional therapy on recurrence and patient survival following liver transplantation for hepatocellular carcinoma: a meta-analysis","volume":"52","author":"X Huang","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/hep.29485","article-title":"Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis","volume":"67","author":"L Kulik","year":"2018","journal-title":"Hepatology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/TP.0000000000001936","article-title":"Systematic Review and Meta-Analysis of Posttransplant Hepatic Artery and Biliary Complications in Patients Treated With Transarterial Chemoembolization Before Liver Transplantation","volume":"102","author":"D Sneiders","year":"2018","journal-title":"Transplantation"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/hep.31992","article-title":"Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant","volume":"74","author":"T Wong","year":"2021","journal-title":"Hepatology"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2017.02.022","article-title":"Stereotactic body radiotherapy vs TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma An intention-to-treat analysis","volume":"67","author":"G Sapisochin","year":"2017","journal-title":"J Hepatol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2019.10.006","article-title":"Extended criteria for liver transplantation in hepatocellular carcinoma A retrospective, multicentric validation study in Belgium","author":"H Degroote","year":"2019","journal-title":"Surg Oncol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/lt.24169","article-title":"Downstaging hepatocellular carcinoma: A systematic review and pooled analysis","volume":"21","author":"N D Parikh","year":"2015","journal-title":"Liver Transpl"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.sla.0000201480.65519.b8","article-title":"A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma","volume":"243","author":"M S Chen","year":"2006","journal-title":"Ann Surg"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2012.05.007","article-title":"A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma","volume":"57","author":"K Feng","year":"2012","journal-title":"J Hepatol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/SLA.0b013e3181efc656","article-title":"A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria","volume":"252","author":"J Huang","year":"2010","journal-title":"Ann Surg"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/bjs.10677","article-title":"Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma","volume":"104","author":"K KC Ng","year":"2017","journal-title":"Br J Surg"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jhep.2014.03.012","article-title":"Partial hepatectomy vs transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT","volume":"61","author":"L Yin","year":"2014","journal-title":"J Hepatol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"R Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/jgh.12791","article-title":"Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial","volume":"30","author":"G G Di Costanzo","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.dld.2013.10.015","article-title":"An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma","volume":"46","author":"A Cucchetti","year":"2014","journal-title":"Dig Liver Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JCO.2012.42.9936","article-title":"Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial","volume":"31","author":"Z W Peng","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/bjs.10061","article-title":"Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria","volume":"103","author":"H Liu","year":"2016","journal-title":"Br J Surg"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1080\/00365521.2018.1548645","article-title":"Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma","volume":"53","author":"K Endo","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"C M Lo","year":"2002","journal-title":"Hepatology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"J Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/bjc.2014.199","article-title":"Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma","volume":"111","author":"R Golfieri","year":"2014","journal-title":"Br J Cancer"},{"key":"ref61","first-page":"Cd011313","article-title":"Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma","volume":"1","author":"O Abdel-Rahman","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1055\/s-0043-124870","article-title":"Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial","volume":"50","author":"J Yang","year":"2018","journal-title":"Endoscopy"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00330-016-4548-3","article-title":"Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus (90)Y-radioembolization for hepatocellular carcinoma","volume":"27","author":"J M Ludwig","year":"2017","journal-title":"Eur Radiol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.2147\/OTT.S175715","article-title":"Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials","volume":"11","author":"A Casadei Gardini","year":"2018","journal-title":"Onco Targets Ther"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijrobp.2017.09.001","article-title":"Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma","volume":"100","author":"E Sapir","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"07","key":"ref66","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/hepr.13647","article-title":"Comparison of stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: Systematic review and meta-analysis of propensity score studies","volume":"51","author":"T Eriguchi","year":"2021","journal-title":"Hepatol Res"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"100594","DOI":"10.1016\/j.jhepr.2022.100594","article-title":"Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis","volume":"5","author":"C Rim","year":"2023","journal-title":"JHEP Rep"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2022.11.013","article-title":"Insights From Image Guided Radiation Therapy Credentialing for the NRG Oncology RTOG 1112 Liver Stereotactic Body Radiation Therapy Trial","author":"T Craig","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.radonc.2018.12.005","article-title":"Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies","volume":"131","author":"C Rim","year":"2019","journal-title":"Radiother Oncol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"653141","DOI":"10.3389\/fonc.2021.653141","article-title":"Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)","volume":"11","author":"T Brunner","year":"2021","journal-title":"Front Oncol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745?articleTools=true","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"R S Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"A L Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"M Kudo","year":"2018","journal-title":"The Lancet"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"J Bruix","year":"2017","journal-title":"The Lancet"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1717002?articleTools=true","article-title":"Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma","volume":"379","author":"G K Abou-Alfa","year":"2018","journal-title":"N Engl J Med"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1470-2045(18)30937-9","article-title":"Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased \u03b1-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"A X Zhu","year":"2019","journal-title":"Lancet Oncol"},{"issue":"04","key":"ref77","first-page":"2379","article-title":"Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: a systematic review and meta-analysis","volume":"13","author":"A Facciorusso","year":"2021","journal-title":"Am J Transl Res"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857?articleTools=true","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"J M Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jhep.2016.07.020","article-title":"Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study","volume":"65","author":"J A Marrero","year":"2016","journal-title":"J Hepatol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1158\/1078-0432.CCR-16-0919","article-title":"Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study","volume":"23","author":"T M Ganten","year":"2017","journal-title":"Clin Cancer Res"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s10637-018-0621-x","article-title":"Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective study","volume":"36","author":"C RG Leal","year":"2018","journal-title":"Invest New Drugs"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/annonc\/mds343","article-title":"Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis","volume":"24","author":"T Pressiani","year":"2013","journal-title":"Ann Oncol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10637-015-0237-3","article-title":"Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors","volume":"33","author":"S Ogasawara","year":"2015","journal-title":"Invest New Drugs"},{"issue":"03","key":"ref84","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2021.04.047","article-title":"CheckMate 040 cohort 5: A phase I\/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis","volume":"75","author":"M Kudo","year":"2021","journal-title":"J Hepatol"},{"issue":"01","key":"ref85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial","volume":"23","author":"T Yau","year":"2022","journal-title":"Lancet Oncol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"V Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2017.76.0892","article-title":"SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma","volume":"36","author":"P KH Chow","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2016.01.012","article-title":"Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial","volume":"64","author":"R Lencioni","year":"2016","journal-title":"J Hepatol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S2468-1253(17)30156-5","article-title":"Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial","volume":"2","author":"T Meyer","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"J Bruix","year":"2017","journal-title":"Lancet"},{"issue":"03","key":"ref91","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JCO.19.01307","article-title":"Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial","volume":"38","author":"R Finn","year":"2020","journal-title":"J Clin Oncol"},{"issue":"05","key":"ref92","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12072-020-10064-8","article-title":"Clinical benefits of PD-1\/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis","volume":"14","author":"Q Rao","year":"2020","journal-title":"Hepatol Int"},{"issue":"05","key":"ref93","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/cer-2020-0236","article-title":"Network meta-analysis of nivolumab plus ipilimumab in the second-line setting for advanced hepatocellular carcinoma","volume":"10","author":"N Parikh","year":"2021","journal-title":"J Comp Eff Res"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"626984","DOI":"10.3389\/fonc.2021.626984","article-title":"The Efficacy and Safety of Programmed Death-1 and Programmed Death Ligand 1 Inhibitors for the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis","volume":"11","author":"S He","year":"2021","journal-title":"Front Oncol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2022.02.009","article-title":"Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib","volume":"167","author":"M Kudo","year":"2022","journal-title":"Eur J Cancer"},{"issue":"11","key":"ref96","doi-asserted-by":"crossref","first-page":"e204564","DOI":"10.1001\/jamaoncol.2020.4564","article-title":"Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial","volume":"6","author":"T Yau","year":"2020","journal-title":"JAMA Oncol"},{"key":"ref97","first-page":"CD011129","article-title":"Early palliative care for adults with advanced cancer","volume":"6","author":"M W Haun","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref98","first-page":"660","article-title":"[Integration of palliative care into intensive care: Systematic review]","volume":"66","author":"K Adler","year":"2017","journal-title":"Anaesthesist"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S1478951513001338","article-title":"Early integration of palliative care in hospitals: A systematic review on methods, barriers, and outcome","volume":"12","author":"K M Dalgaard","year":"2014","journal-title":"Palliat Support Care"},{"key":"ref100","first-page":"99","article-title":"A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses","volume":"4","author":"M P Davis","year":"2015","journal-title":"Ann Palliat Med"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1634\/theoncologist.2014-0312","article-title":"Integration of oncology and palliative care: a systematic review","volume":"20","author":"D Hui","year":"2015","journal-title":"Oncologist"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1634\/theoncologist.2016-0006","article-title":"Referral Criteria for Outpatient Palliative Cancer Care: A Systematic Review","volume":"21","author":"D Hui","year":"2016","journal-title":"Oncologist"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1574887110666151014141650","article-title":"Early Palliative Care in Advanced Oncologic and Non-Oncologic Chronic Diseases: A Systematic Review of Literature","volume":"11","author":"D Tassinari","year":"2016","journal-title":"Rev Recent Clin Trials"},{"key":"ref104","first-page":"501","article-title":"[Physical complaints, stress and quality of life of oncologic patients Effects and patient assessment in inpatient rehabilitation]","volume":"91","author":"U G\u00e4rtner","year":"1996","journal-title":"Med Klin (Munich)"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ijc.25362?download=true","article-title":"Risk of cancer in a large cohort of US veterans with diabetes","volume":"128","author":"E A Atchison","year":"2011","journal-title":"Int J Cancer"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1478-3231.2011.02614.x?download=true","article-title":"Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort","volume":"32","author":"M B de Valle","year":"2012","journal-title":"Liver Int"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.22606?download=true","article-title":"Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of US veterans","volume":"49","author":"H B El-Serag","year":"2009","journal-title":"Hepatology"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"100570","DOI":"10.18632\/oncotarget.20141","article-title":"Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis","volume":"8","author":"Y Huang","year":"2017","journal-title":"Oncotarget"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CEJ.0b013e3283481d89","article-title":"Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis","volume":"21","author":"W Jing","year":"2012","journal-title":"Eur J Cancer Prev"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"W C Palmer","year":"2012","journal-title":"J Hepatol"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12876-017-0696-4","article-title":"Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis","volume":"17","author":"N Wongjarupong","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1440-1746.2008.05689.x?download=true","article-title":"Long-term follow up of gallbladder polyps","volume":"24","author":"J Y Park","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/apt.12655?download=true","article-title":"Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer","volume":"39","author":"V Nagaraja","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref115","first-page":"497942","article-title":"Radiological Imaging for Assessing the Respectability of Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis","volume":"2015","author":"H Zhang","year":"2015","journal-title":"Biomed Res Int"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/2303-9027.193597","article-title":"Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture: Systematic review and meta-analysis","volume":"7","author":"D TH De Moura","year":"2018","journal-title":"Endosc Ultrasound"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.gie.2015.04.030","article-title":"Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review","volume":"82","author":"U Navaneethan","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11605-007-0335-4","article-title":"Outcomes analysis for 280\u00a0patients with cholangiocarcinoma treated with liver transplantation over an 18-year period","volume":"12","author":"N S Becker","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Murad S Darwish","year":"2012","journal-title":"Gastroenterology"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.2147\/OTT.S202875","article-title":"A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma","volume":"12","author":"Y Zhen","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"05","key":"ref121","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00270-021-02800-w","article-title":"Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis","volume":"44","author":"C Mosconi","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"J N Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721?articleTools=true","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"J Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjc.6605779","article-title":"Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan","volume":"103","author":"T Okusaka","year":"2010","journal-title":"Br J Cancer"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/annonc\/mdt540","article-title":"Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials","volume":"25","author":"J W Valle","year":"2014","journal-title":"Ann Oncol"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4143\/crt.2014.308","article-title":"Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review","volume":"47","author":"J O Park","year":"2015","journal-title":"Cancer Res Treat"},{"issue":"07","key":"ref127","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071975","article-title":"Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial","volume":"12","author":"A Markussen","year":"2020","journal-title":"Cancers (Basel)"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer","volume":"1","author":"D Oh","year":"2022","journal-title":"NEJM Evidence"},{"issue":"05","key":"ref129","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"G Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"issue":"09","key":"ref130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.annonc.2022.05.519","article-title":"Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study","volume":"33","author":"M Maio","year":"2022","journal-title":"Ann Oncol"},{"issue":"05","key":"ref131","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","article-title":"Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial","volume":"22","author":"A Lamarca","year":"2021","journal-title":"Lancet Oncol"},{"issue":"11","key":"ref132","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jamaoncol.2021.3836","article-title":"Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial","volume":"7","author":"A Zhu","year":"2021","journal-title":"JAMA Oncol"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejca.2021.06.019","article-title":"A randomised phase II study of oxaliplatin\/5-FU (mFOLFOX) versus irinotecan\/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine\/cisplatin chemotherapy","volume":"154","author":"I Choi","year":"2021","journal-title":"Eur J Cancer"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/SLA.0000000000002381","article-title":"Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium","volume":"266","author":"V G Agopian","year":"2017","journal-title":"Ann Surg"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000342813","article-title":"Multimodality treatment for early-stage hepatocellular carcinoma: a bridging therapy for liver transplantation","volume":"86","author":"N Ashoori","year":"2012","journal-title":"Digestion"},{"key":"ref137","first-page":"143","article-title":"Pretransplant Locoregional Therapy for Hepatocellular Carcinoma: Evaluation of Explant Pathology and Overall Survival","volume":"6","author":"E W Beal","year":"2016","journal-title":"Front Oncol"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"e13255","DOI":"10.1111\/ctr.13255","article-title":"The impact of transarterial chemoembolization induced complications on outcomes after liver transplantation: A propensity-matched study","volume":"32","author":"A Boteon","year":"2018","journal-title":"Clin Transplant"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.transproceed.2017.09.063","article-title":"Liver Transplantation in Patients With Hepatocellular Carcinoma Outside the Milan Criteria After Downstaging: Is It Worth It?","volume":"50","author":"P Cascales-Campos","year":"2018","journal-title":"Transplant Proc"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/liv.12966","article-title":"Excellent post-transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy","volume":"36","author":"A Finkenstedt","year":"2016","journal-title":"Liver Int"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejrad.2017.05.022","article-title":"Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization","volume":"93","author":"A Gabr","year":"2017","journal-title":"Eur J Radiol"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s10353-017-0487-8","article-title":"Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation","volume":"49","author":"G P Gy\u00f6ri","year":"2017","journal-title":"Eur Surg"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jvir.2018.11.037","article-title":"Association of Complete Radiologic and Pathologic Response following Locoregional Therapy before Liver Transplantation with Long-Term Outcomes of Hepatocellular Carcinoma: A Retrospective Study","volume":"30","author":"P Habibollahi","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"41624","DOI":"10.1038\/srep41624","article-title":"Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma","volume":"7","author":"L Jianyong","year":"2017","journal-title":"Sci Rep"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/hep.20688","article-title":"Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation","volume":"41","author":"D S Lu","year":"2005","journal-title":"Hepatology"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jvir.2009.10.038","article-title":"Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma","volume":"21","author":"A Nicolini","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1148\/radiol.2016160288","article-title":"Effect of Bridging Local-Regional Therapy on Recurrence of Hepatocellular Carcinoma and Survival after Orthotopic Liver Transplantation","volume":"282","author":"H C Oligane","year":"2017","journal-title":"Radiology"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jvir.2018.12.736","article-title":"Bridging Hepatocellular Carcinoma to Transplant: Transarterial Chemoembolization Response, Tumor Biology, and Recurrence after Transplantation in a 12-Year Transplant Cohort","volume":"30","author":"T Sandow","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14701\/ahbps.2018.22.1.27","article-title":"Bridging therapies to liver transplantation for hepatocellular carcinoma: A bridge to nowhere?","volume":"22","author":"C HN Tan","year":"2018","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"ref150","first-page":"638","article-title":"Neoadjuvant Transarterial Chemoembolization Improves Survival After Liver Transplant in Patients With Hepatocellular Carcinoma","volume":"17","author":"J D Werner","year":"2019","journal-title":"Exp Clin Transplant"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2017.02.022","article-title":"Stereotactic body radiotherapy vs TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma An intention-to-treat analysis","volume":"67","author":"G Sapisochin","year":"2017","journal-title":"J Hepatol"},{"key":"ref152","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.27752","article-title":"Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria","volume":"61","author":"F Y Yao","year":"2015","journal-title":"Hepatology"},{"key":"ref153","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-230X-11-143","article-title":"Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma","volume":"11","author":"H Nishikawa","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"ref154","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2011.05.020","article-title":"Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early\/early stage hepatocellular carcinoma","volume":"56","author":"J H Wang","year":"2012","journal-title":"J Hepatol"},{"key":"ref155","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1148\/radiol.11110817","article-title":"Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study","volume":"262","author":"Z W Peng","year":"2012","journal-title":"Radiology"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2012.11.009","article-title":"Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey","volume":"58","author":"K Hasegawa","year":"2013","journal-title":"J Hepatol"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/jgh.12441","article-title":"Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma","volume":"29","author":"Y Fang","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/hpb.12446","article-title":"Surgical resection versus ablation for hepatocellular carcinoma \u2264 3 cm: a population-based analysis","volume":"17","author":"J T Miura","year":"2015","journal-title":"HPB (Oxford)"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.2147\/OTT.S141968","article-title":"Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta-analysis","volume":"10","author":"M Zhang","year":"2017","journal-title":"Onco Targets Ther"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/02656736.2016.1257824?needAccess=true","article-title":"Microwave ablation versus hepatic resection for the treatment of hepatocellular carcinoma and oesophageal variceal bleeding in cirrhotic patients","volume":"33","author":"Q B Zhang","year":"2017","journal-title":"Int J Hyperthermia"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/SLA.0000000000001178","article-title":"Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma \u2264 2 \u200acm in a Propensity Score Model","volume":"263","author":"P H Liu","year":"2016","journal-title":"Ann Surg"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/liv.13670","article-title":"Impact of resection and ablation for single hypovascular hepatocellular carcinoma \u22642 cm analysed with propensity score weighting","volume":"38","author":"K Takayasu","year":"2018","journal-title":"Liver Int"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s00330-018-5902-4","article-title":"Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database","volume":"29","author":"J Uhlig","year":"2019","journal-title":"Eur Radiol"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cgh.2010.08.018","article-title":"Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas","volume":"9","author":"H H Hung","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref165","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/13651820510028846","article-title":"Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomes","volume":"7","author":"M Ogihara","year":"2005","journal-title":"HPB (Oxford)"},{"key":"ref166","first-page":"801","article-title":"[Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial]","volume":"86","author":"M D L\u00fc","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref167","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/13651820701713758","article-title":"Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?","volume":"9","author":"L Lupo","year":"2007","journal-title":"HPB (Oxford)"},{"key":"ref168","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s11605-008-0553-4","article-title":"Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma","volume":"12","author":"M Abu-Hilal","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"ref169","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jso.21745","article-title":"Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection","volume":"104","author":"H Tashiro","year":"2011","journal-title":"J Surg Oncol"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3348\/kjr.2013.14.4.626","article-title":"Radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of single hepatocellular carcinoma of 2 to 5 cm in diameter: comparison with surgical resection","volume":"14","author":"J W Kim","year":"2013","journal-title":"Korean J Radiol"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"e3754","DOI":"10.1097\/MD.0000000000003754","article-title":"Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study","volume":"95","author":"C Tang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s12094-016-1611-0","article-title":"Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control study","volume":"19","author":"A K Bholee","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"ref173","first-page":"3506","article-title":"Comparison of Combined Transcatheter Arterial Chemoembolization and CT-guided Radiofrequency Ablation with Surgical Resection in Patients with Hepatocellular Carcinoma within the Up-to-seven Criteria: A Multicenter Case-matched Study","volume":"8","author":"T Pan","year":"2017","journal-title":"J\u00a0Cancer"},{"key":"ref174","first-page":"219","article-title":"Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma","volume":"24","author":"R Zhang","year":"2018","journal-title":"Diagn Interv Radiol"},{"key":"ref175","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"J M Llovet","year":"2002","journal-title":"Lancet"},{"key":"ref176","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0016-5085(88)90436-2","article-title":"Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial","volume":"94","author":"D Y Lin","year":"1988","journal-title":"Gastroenterology"},{"key":"ref177","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0168-8278(90)90110-D","article-title":"A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma","volume":"11","author":"G Pelletier","year":"1990","journal-title":"J Hepatol"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1056\/NEJM199505113321903?articleTools=true","article-title":"A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma","volume":"332","year":"1995","journal-title":"N Engl J Med"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/hep.510270617?download=true","article-title":"Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution","volume":"27","author":"J Bruix","year":"1998","journal-title":"Hepatology"},{"key":"ref180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(98)80187-6","article-title":"Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial Groupe CHC","volume":"29","author":"G Pelletier","year":"1998","journal-title":"J Hepatol"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/1097-0142%2819950515%2975%3A10%3C2427%3A%3AAID-CNCR2820751007%3E3.0.CO%3B2-J?download=true","article-title":"Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma An Italian experience","volume":"75","author":"G F Stefanini","year":"1995","journal-title":"Cancer"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/1097-0142%2819940701%2974%3A1%3C16%3A%3AAID-CNCR2820740105%3E3.0.CO%3B2-V?download=true","article-title":"Transcatheter oily chemoembolization for hepatocellular carcinoma A 4-year study of 127 French patients","volume":"74","author":"J P Bronowicki","year":"1994","journal-title":"Cancer"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/j.1365-2036.2009.04016.x?download=true","article-title":"Transcatheter arterial chemoembolization vs chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis","volume":"29","author":"J H Kim","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s00270-007-9032-7","article-title":"Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma","volume":"30","author":"S Herber","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref185","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1148\/radiol.10101058","article-title":"Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival","volume":"258","author":"G E Chung","year":"2011","journal-title":"Radiology"},{"key":"ref186","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/01.RVI.0000182185.47500.7A","article-title":"Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis","volume":"16","author":"C S Georgiades","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"ref187","first-page":"535","article-title":"Transcatheter arterial embolization for inoperable hepatocellular carcinoma","volume":"36","author":"M Okazaki","year":"1991","journal-title":"Jpn J Clin Radiol"},{"key":"ref188","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jvir.2011.07.002","article-title":"Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma","volume":"22","author":"R Sacco","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000329602","article-title":"A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma","volume":"34","author":"H van Malenstein","year":"2011","journal-title":"Onkologie"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/jso.21522?download=true","article-title":"Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)","volume":"101","author":"R Dhanasekaran","year":"2010","journal-title":"J Surg Oncol"},{"key":"ref191","first-page":"246","article-title":"[Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma]","volume":"53","author":"M D Ferrer Puchol","year":"2011","journal-title":"Radiologia"},{"key":"ref192","doi-asserted-by":"crossref","first-page":"Cr189","DOI":"10.12659\/MSM.881714","article-title":"Transarterial Chemoembolization of Child-A hepatocellular carcinoma: drug-eluting bead TACE (DEB TACE) vs TACE with cisplatin\/lipiodol (cTACE)","volume":"17","author":"P Wiggermann","year":"2011","journal-title":"Med Sci Monit"},{"key":"ref193","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jhep.2012.07.017","article-title":"Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma","volume":"57","author":"M J Song","year":"2012","journal-title":"J Hepatol"},{"key":"ref194","first-page":"496","article-title":"Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs","volume":"57","author":"J E Meg\u00edas Vericat","year":"2015","journal-title":"Radiologia"},{"key":"ref195","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s12885-015-1480-x","article-title":"Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma","volume":"15","author":"R Kloeckner","year":"2015","journal-title":"BMC Cancer"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/jgh.13147?download=true","article-title":"Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma","volume":"31","author":"A Facciorusso","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"ref197","first-page":"69","article-title":"Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma","volume":"8","author":"J Baur","year":"2016","journal-title":"Hepat Med"},{"key":"ref198","first-page":"813","article-title":"Doxorubicin-eluting bead versus conventional TACE for unresectable hepatocellular carcinoma: a meta-analysis","volume":"60","author":"S Gao","year":"2013","journal-title":"Hepatogastroenterology"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/jgh.12439?download=true","article-title":"Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma","volume":"29","author":"K Huang","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"ref200","first-page":"3892","article-title":"Doxorubicin-eluting beads versus conventional transarterialchemoembolization for the treatment of hepatocellular carcinoma: a meta-analysis","volume":"7","author":"X Zhou","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/1751-2980.12380?download=true","article-title":"Efficacy and safety of cTACE versus DEB-TACE in patients with hepatocellular carcinoma: a meta-analysis","volume":"17","author":"J H Zou","year":"2016","journal-title":"J Dig Dis"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.dld.2016.02.005","article-title":"Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis","volume":"48","author":"A Facciorusso","year":"2016","journal-title":"Dig Liver Dis"},{"key":"ref203","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"R Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/hep.26014?download=true","article-title":"Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study","volume":"57","author":"V Mazzaferro","year":"2013","journal-title":"Hepatology"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep.23944?download=true","article-title":"Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival","volume":"52","author":"P Hilgard","year":"2010","journal-title":"Hepatology"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/hep.21980?download=true","article-title":"Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis","volume":"47","author":"L M Kulik","year":"2008","journal-title":"Hepatology"},{"key":"ref207","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2468-1253(18)30234-6","article-title":"Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial","volume":"3","author":"R JS Coelen","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref208","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejso.2017.04.001","article-title":"Preoperative biliary drainage in hilar cholangiocarcinoma: Systematic review and meta-analysis","volume":"43","author":"A Celotti","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"E203","DOI":"10.1055\/a-0990-9114","article-title":"Percutaneous transhepatic biliary drainage may be the preferred preoperative drainage method in hilar cholangiocarcinoma","volume":"8","author":"Y Ba","year":"2020","journal-title":"Endosc Int Open"},{"key":"ref210","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1007\/s11605-018-3861-3","article-title":"Preoperative Biliary Drainage Is Associated with Increased Complications After Liver Resection for Proximal Cholangiocarcinoma","volume":"22","author":"R Ramanathan","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5582\/bst.2017.01107","article-title":"Preoperative biliary drainage versus direct surgery for perihilar cholangiocarcinoma: A retrospective study at a single center","volume":"11","author":"Y Cai","year":"2017","journal-title":"Biosci Trends"},{"key":"ref212","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/bjs.8950?download=true","article-title":"Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma","volume":"100","author":"O Farges","year":"2013","journal-title":"Br J Surg"},{"key":"ref213","doi-asserted-by":"crossref","first-page":"8731","DOI":"10.3748\/wjg.v19.i46.8731","article-title":"Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy","volume":"19","author":"J J Xiong","year":"2013","journal-title":"World J Gastroenterol"},{"key":"ref214","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12957-019-1656-y","article-title":"A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction","volume":"17","author":"L Wang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"ref215","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/jcm8040458","article-title":"Relevance of Preoperative Hyperbilirubinemia in Patients Undergoing Hepatobiliary Resection for Hilar Cholangiocarcinoma","volume":"8","author":"K M Wronka","year":"2019","journal-title":"J Clin Med"},{"key":"ref216","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00423-016-1427-y","article-title":"The type of preoperative biliary drainage predicts short-term outcome after major hepatectomy","volume":"401","author":"Y Kishi","year":"2016","journal-title":"Langenbecks Arch Surg"},{"key":"ref217","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/jgh.14050?download=true","article-title":"Multicenter study of endoscopic preoperative biliary drainage for malignant hilar biliary obstruction: E-POD hilar study","volume":"33","author":"Y Nakai","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"ref218","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.surg.2016.08.008","article-title":"Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A\u00a0propensity score matching analysis of resectable perihilar cholangiocarcinoma","volume":"161","author":"K Komaya","year":"2017","journal-title":"Surgery"},{"key":"ref219","doi-asserted-by":"crossref","first-page":"791","DOI":"10.5009\/gnl14243","article-title":"A Comparison of Preoperative Biliary Drainage Methods for Perihilar Cholangiocarcinoma: Endoscopic versus Percutaneous Transhepatic Biliary Drainage","volume":"9","author":"K M Kim","year":"2015","journal-title":"Gut Liver"},{"key":"ref220","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0016-5107(02)70356-8","article-title":"Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life","volume":"56","author":"N S Abraham","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.gie.2008.04.005","article-title":"Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach","volume":"69","author":"W H Paik","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"ref222","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(94)90455-3","article-title":"Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction","volume":"344","author":"A C Smith","year":"1994","journal-title":"Lancet"},{"key":"ref223","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(87)92733-4","article-title":"Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice","volume":"2","author":"A G Speer","year":"1987","journal-title":"Lancet"},{"key":"ref224","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1067\/mge.2001.113381","article-title":"Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study","volume":"53","author":"G D De Palma","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"ref225","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.cgh.2008.03.028","article-title":"Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment","volume":"6","author":"S S Saluja","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref226","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.gie.2012.02.048","article-title":"Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial","volume":"76","author":"A Sangchan","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"ref227","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1067\/mge.2002.125364","article-title":"Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents","volume":"56","author":"J L Cheng","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"ref228","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.gie.2019.03.011","article-title":"Prospective comparison of endoscopic bilateral stent-in-stent versus stent-by-stent deployment for inoperable advanced malignant hilar biliary stricture","volume":"90","author":"T H Lee","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"ref229","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00270-011-0103-4","article-title":"British Society of Interventional Radiology: Biliary Drainage and Stenting Registry (BDSR)","volume":"35","author":"R Uberoi","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref230","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41395-018-0122-8","article-title":"EUS-Guided Biliary Drainage Versus ERCP for the Primary Palliation of Malignant Biliary Obstruction: A Multicenter Randomized Clinical Trial","volume":"113","author":"W H Paik","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.gie.2018.03.012","article-title":"Stent placement by EUS or ERCP for primary biliary decompression in pancreatic cancer: a randomized trial (with videos)","volume":"88","author":"J Y Bang","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"ref232","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.gastro.2003.07.015","article-title":"Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study","volume":"125","author":"M E Ortner","year":"2003","journal-title":"Gastroenterology"},{"key":"ref233","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1067\/mge.2001.119605","article-title":"Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer","volume":"54","author":"T Zoepf","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"ref234","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/j.1572-0241.2005.00318.x","article-title":"Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy","volume":"100","author":"T Zoepf","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref235","first-page":"e000379","article-title":"PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer","volume":"3","author":"S P Pereira","year":"2018","journal-title":"ESMO Open"},{"key":"ref236","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cgh.2007.12.004","article-title":"Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy","volume":"6","author":"M Kahaleh","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref237","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/apt.15050?download=true","article-title":"Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma","volume":"49","author":"M A Gonzalez-Carmona","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"ref238","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.gie.2014.02.1030","article-title":"ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma","volume":"80","author":"D S Strand","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"ref239","doi-asserted-by":"crossref","first-page":"470","DOI":"10.5009\/gnl15175","article-title":"Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma","volume":"10","author":"R Wentrup","year":"2016","journal-title":"Gut Liver"},{"key":"ref240","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/2050640616654037","article-title":"Photodynamic therapy with polyhematoporphyrin for malignant biliary obstruction: A nationwide retrospective study of 150 consecutive applications","volume":"5","author":"W Dolak","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4253\/wjge.v6.i1.13","article-title":"Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction","volume":"6","author":"A O Tal","year":"2014","journal-title":"World J Gastrointest Endosc"}],"container-title":["Zeitschrift f\u00fcr Gastroenterologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2189-8461.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T20:02:05Z","timestamp":1764187325000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2189-8461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":239,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2024,1,9]]},"published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2189-8461","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0044-2771","1439-7803"],"issn-type":[{"type":"print","value":"0044-2771"},{"type":"electronic","value":"1439-7803"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}